CEM supported sites showed a 181% increase in pre-screening rates following calls
Paediatric Case Study: Type II Diabetes Phase IIIa
The study sponsor approached Innovative Trials to aid recruitment activities on this Phase IIIa rescue study, where targets were not being met. Despite challenging inclusion criteria, this study saw success in recruiting children and adolescents with Type II Diabetes.
Sites receiving diversity outreach visits saw a 63% increase in randomised patients than those without.
Diversity Outreach Case Study: Active SLE Phase III
Innovative Trials’ services were rolled out to support the study sponsor with community outreach for this Phase III Active Systemic Lupus Erythematosus (SLE) study. The study looked to increase awareness access to clinical trials amongst diverse communities.
Rapid implementation of a 2-month rescue pilot led to a 113% increase in randomisation rates, getting the study back on schedule.
Rescue Case Study: Oncology Phase III
A leading biopharmaceutical company approached Innovative Trials to increase enrolment for their phase III study of Metastatic Colorectal Cancer (mCRC). The study needed to enroll 1250 eligible patients, however sites were experiencing severe enrolment fatigue and enrolment was lagging.
Community Outreach Boosted Enrolment for a Birth Control Study.
Community Outreach Case Study: Women’s Health Phase III
Innovative Trials were approached to support a mid size pharmaceutical company to accelerate enrolment for a Phase III birth control study in the US. The study needed to enrol 1357 healthy women aged 18-35 in a 7 month period.